Dr. Lal Pathlabs share price
You have to be logged in to add this to Watchlist.Dr. Lal Pathlabs is trading 1.21% upper at Rs 3,357.95 as compared to its last closing price. Dr. Lal Pathlabs has been trading in the price range of 3,382.50 & 3,301.05. Dr. Lal Pathlabs has given 28.51% in this year & -6.13% in the last 5 days.
Dr. Lal Pathlabs has TTM P/E ratio 60.60 as compared to the sector P/E of 29.87.There are 20 analysts who have initiated coverage on Dr. Lal Pathlabs. There are 1 analysts who have given it a strong buy rating & 8 analysts have given it a buy rating. 3 analysts have given the stock a sell rating.
The company posted a net profit of 106.40 Crores in its last quarter.
Listed peers of Dr. Lal Pathlabs include Max Healthcare Institute (-0.10%), Fortis Healthcare (1.13%), Dr. Lal Pathlabs (1.21%) etc.
Dr. Lal Pathlabs has a 45.75% public holding.The Mutual Fund holding in Dr. Lal Pathlabs was at 2.54% in 30 Sep 2024. The MF holding has decreased from the last quarter. The FII holding in Dr. Lal Pathlabs was at 26.82% in 30 Sep 2024. The FII holding has increased from the last quarter.
Dr. Lal Pathlabs share price range
|
| ||||
|
| ||||
Dr. Lal Pathlabs share Key Metrics
| Market Cap ( ₹ Cr.) | 27,593.59 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Dr. Lal Pathlabs Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 23-Oct-24 | Quarterly Results & Interim Dividend |
| 07-Aug-24 | Quarterly Results & Interim Dividend |
| 10-May-24 | Audited Results & Final Dividend |
| 01-Feb-24 | Quarterly Results & Interim Dividend |
| 02-Nov-23 | Quarterly Results |
| 27-Jul-23 | Quarterly Results & Interim Dividend |
| 11-May-23 | Audited Results & Final Dividend |
| 02-Feb-23 | Quarterly Results |
| 08-Nov-22 | Quarterly Results |
| 28-Jul-22 | Quarterly Results & Interim Dividend |
| Meeting Date | Announcement On | Purpose |
| 29-Jun-24 | 10-May-24 | AGM |
| 12-Sep-23 | 27-Jul-23 | AGM |
| 12-Mar-23 | 08-Feb-23 | POM |
| 30-Jun-22 | 17-May-22 | AGM |
| 29-Jul-21 | 21-May-21 | AGM |
| Announcement On | Record Date | Ex-Dividend | Dividend Value |
| 07-Aug-24 | 20-Aug-24 | 20-Aug-24 | 6 |
| 10-May-24 | 10-Jun-24 | 10-Jun-24 | 6 |
| 01-Feb-24 | 13-Feb-24 | 13-Feb-24 | 12 |
| 11-May-23 | 11-Aug-23 | 11-Aug-23 | 6 |
| 27-Jul-23 | 11-Aug-23 | 11-Aug-23 | 6 |
| 28-Jul-22 | 09-Aug-22 | 05-Aug-22 | 6 |
| 17-May-22 | 23-Jun-22 | 22-Jun-22 | 6 |
| 30-Jul-21 | 22-Aug-21 | 18-Aug-21 | 6 |
| 21-May-21 | 22-Jul-21 | 20-Jul-21 | 8 |
| 29-Jan-21 | 10-Feb-21 | 09-Feb-21 | 6 |
FAQs about Dr. Lal Pathlabs share price
Dr. Lal Pathlabs is trading at 3357.95 as on Fri Oct 18 2024 09:59:43. This is 1.21% upper as compared to its previous closing price of 3317.80.
The market capitalization of Dr. Lal Pathlabs is 27970.51 Cr as on Fri Oct 18 2024 09:59:43.
The average broker rating on Dr. Lal Pathlabs is Hold. The breakup of analyst rating is given below -
- 1 analysts have given a strong buy rating
- 8 analysts have given a buy rating
- 4 analysts have given a hold rating
- 3 analysts have given a sell rating
- 4 analysts have given a strong sell rating
The 52 wk high for Dr. Lal Pathlabs is 3645.00 whereas the 52 wk low is 1943.20
Dr. Lal Pathlabs can be analyzed on the following key metrics -
- TTM P/E: 60.60
- Sector P/E: 29.87
- Dividend Yield: 0.91%
- D/E ratio: -
Dr. Lal Pathlabs reported a net profit of 357.70 Cr in 2024.
Dr. Lal Pathlabs Quick Links
Dr. Lal Pathlabs Dividend Dr. Lal Pathlabs Bonus Dr. Lal Pathlabs News Dr. Lal Pathlabs AGM Dr. Lal Pathlabs Rights Dr. Lal Pathlabs Splits Dr. Lal Pathlabs Board Meetings Dr. Lal Pathlabs Key Metrics Dr. Lal Pathlabs Shareholdings Dr. Lal Pathlabs Profit Loss Dr. Lal Pathlabs Balance Sheet Dr. Lal Pathlabs Cashflow Dr. Lal Pathlabs Q1 Results Dr. Lal Pathlabs Q2 Results Dr. Lal Pathlabs Q3 Results Dr. Lal Pathlabs Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks